Webinar
Join Dr. Robert Haddad and his guests, Drs. David Brizel and Merrill Kies for an engaging exploration of the latest data on the use of EGFR-inhibitors with induction therapy, integration of EGFR-inhibitors with radiation and/or chemotherapy, and the use of HPV screening to help guide treatment decisions.
Agenda
- Presentation of interactive challenging cases
- The role of induction therapy - Should it be revisited?
- Current therapeutic options for the HPV +/- patient
- Integration of EGFR inhibitors with radiation/chemoradiation
- Panel discussion and Q&A
DocTalk
On demand | Available November 7, 2011
Agenda:
- Debate: The role of induction therapy should be revisited
- Point: Yes, it should be actively incorporated in the treatment – 5 minutes
- Counterpoint: No, there is no significant benefit for the patient – 5 minutes
- Questions for the moderator – 10 minutes
- Case presentation and discussion - faculty panel will discuss optimal management/best way to proceed.
- Current therapeutic options for the HPV +/- patient
- The impact of HPV status on treatment
- Integration of EGFR inhibitors with radiation/chemoradiation